Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab

被引:0
|
作者
Lee, Min Young [1 ,2 ]
Lee, Woo In [1 ,2 ]
Kang, So Young [1 ,2 ]
Kim, Myeong Hee [1 ,2 ]
Park, Young Shil [2 ,3 ]
机构
[1] Kyung Hee Univ, Sch Med, Dept Lab Med, 892 Dongnam Ro, Seoul 05278, South Korea
[2] Kyung Hee Univ Hosp Gangdong, 892 Dongnam Ro, Seoul 05278, South Korea
[3] Kyung Hee Univ, Sch Med, Dept Pediat, Seoul, South Korea
关键词
D O I
10.3343/alm.2023.43.1.96
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:96 / 99
页数:4
相关论文
共 50 条
  • [31] Prevention of Bleeding in Patients with Moderate and Severe Hemophilia A Playing Sports: A Comparison between Factor VIII and Emicizumab Prophylaxis (STEP: SporTs Emicizumab Prophylaxis)
    Chitlur, Meera B.
    BLOOD, 2022, 140 : 5619 - 5620
  • [32] Factor VIII:C measurement by different chromogenic and one stage assays in two Acquired Haemophilia patients treated with recombinant porcine factor VIII
    Guy, Susan
    Bowyer, Annette
    Kitchen, Steve
    HAEMOPHILIA, 2022, 28 : 47 - 48
  • [33] Laboratory response to paradigm change in hemophilia treatment How to monitor patients simultaneously treated with emicizumab and factor VIII concentrate?
    Lambert, Marjan Shafaati
    Bruzelius, Maria
    Soutari, Nida Mahmoud Hourani
    Ranta, Susanna
    Antovic, Jovan P. P.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2023, 61 (12) : E248 - E250
  • [34] A critical appraisal of one-stage and chromogenic assays of factor VIII activity
    Peyvandi, F.
    Oldenburg, J.
    Friedman, K. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (02) : 248 - 261
  • [35] Coagulation and chromogenic assays of factor VIII activity: General aspects, standardization, and recommendations
    Barrowcliffe, TW
    Raut, S
    Sands, D
    Hubbard, AR
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (03): : 247 - 255
  • [36] Measurement of antifactor VIII antibody titre in the presence of emicizumab; Use of chromogenic Bethesda assays
    Bowyer, Annette
    Kitchen, Steve
    Maclean, Rhona
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (04) : E204 - E206
  • [37] Effects of emicizumab on APTT, one-stage and chromogenic assays of factor VIII in artificially spiked plasma and in samples from haemophilia A patients with inhibitors
    Bowyer, Annette
    Kitchen, Steve
    Maclean, Rhona
    HAEMOPHILIA, 2020, 26 (03) : 536 - 542
  • [38] Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis
    Hermans, Cedric
    Ventriglia, Giuliana
    Obaji, Samya
    Beckermann, Benjamin M.
    Lehle, Michaela
    Catalani, Olivier
    d'Oiron, Roseline
    Frenzel, Laurent
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (08)
  • [39] Factor IX assays in treated hemophilia B patients
    Pouplard, Claire
    Jeanpierre, Emmanuelle
    Lasne, Dominique
    Duchez, Veronique Le Cam
    Eschwege, Valerie
    Flaujac, Claire
    Galinat, Hubert
    Harzallah, Ines
    Proulle, Valerie
    Smahi, Motalib
    Sobas, Frederic
    Ternisien, Catherine
    Toulon, Pierre
    Voisin, Sophie
    Nougier, Christophe
    Gelas, Martine Alhenc
    Biron, Christine
    Blanc-Jouvan, Florence
    Bourgerette, Evelyne
    Bulabois, Benedicte
    Comio, Emilie
    Donnard, Magali
    Duchemin, Jerome
    Faure, Anne-Camille
    Grand, Francois
    Grunebaum, Lelia
    Guicheteau, Maryse
    Hezard, Nathalie
    Hurtaud, Marie-Francoise
    Gac, Fabienne Nedelec
    De Maistre, Emmanuel
    Marlu, Raphael
    Mourey, Guillaume
    Munier, Perrine
    Pineau-Vincent, Fabienne
    Raffenot, Didier
    Repesse, Yohan
    Ryman, Anne
    Sattler, Laurent
    Sauguet, Pauline
    Serre-Sapin, Anne-Francoise
    Stepanian, Alain
    Szymezak, Jean
    Tuffigo, Marie
    Voyer, Annelise
    ANNALES DE BIOLOGIE CLINIQUE, 2019, 77 (01) : 41 - 52
  • [40] Assay design and use of chromogenic factor VIII assays
    Rosen, S.
    HAEMOPHILIA, 2010, 16 : 82 - 82